Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Ischemia | 9 | 2022 | 3001 | 1.090 |
Why?
|
Stroke | 14 | 2024 | 9746 | 0.820 |
Why?
|
Magnetic Resonance Imaging | 19 | 2024 | 36582 | 0.490 |
Why?
|
Cerebral Amyloid Angiopathy | 4 | 2021 | 887 | 0.400 |
Why?
|
Brain | 10 | 2023 | 27163 | 0.370 |
Why?
|
Leukoaraiosis | 2 | 2022 | 114 | 0.370 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2024 | 2811 | 0.360 |
Why?
|
Rectal Neoplasms | 7 | 2016 | 1183 | 0.350 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2021 | 8940 | 0.340 |
Why?
|
Thrombectomy | 4 | 2024 | 676 | 0.330 |
Why?
|
Leukoencephalopathies | 2 | 2020 | 258 | 0.280 |
Why?
|
Familial Mediterranean Fever | 1 | 2008 | 66 | 0.280 |
Why?
|
Diffusion Tensor Imaging | 2 | 2021 | 2421 | 0.280 |
Why?
|
Information Storage and Retrieval | 1 | 2013 | 833 | 0.280 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 258 | 0.270 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2008 | 588 | 0.250 |
Why?
|
Proctitis | 3 | 2009 | 40 | 0.240 |
Why?
|
Recovery of Function | 4 | 2021 | 2978 | 0.210 |
Why?
|
Organoplatinum Compounds | 4 | 2011 | 406 | 0.200 |
Why?
|
Radiation Injuries | 4 | 2010 | 1196 | 0.190 |
Why?
|
Nerve Net | 2 | 2016 | 2307 | 0.190 |
Why?
|
Arteritis | 1 | 2003 | 160 | 0.190 |
Why?
|
Migraine without Aura | 1 | 2022 | 82 | 0.190 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1007 | 0.180 |
Why?
|
Heterocyclic Compounds, 1-Ring | 2 | 2019 | 68 | 0.180 |
Why?
|
Coma | 1 | 2024 | 485 | 0.170 |
Why?
|
Migraine with Aura | 1 | 2022 | 203 | 0.170 |
Why?
|
Benzene Derivatives | 1 | 2019 | 51 | 0.160 |
Why?
|
Cerebral Arterial Diseases | 1 | 2019 | 82 | 0.160 |
Why?
|
2-Aminoadipic Acid | 1 | 2019 | 32 | 0.160 |
Why?
|
Endovascular Procedures | 3 | 2024 | 2215 | 0.160 |
Why?
|
Brain Infarction | 1 | 2020 | 285 | 0.160 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2019 | 112 | 0.160 |
Why?
|
Fluorouracil | 4 | 2011 | 1652 | 0.150 |
Why?
|
Middle Aged | 34 | 2024 | 223233 | 0.150 |
Why?
|
Pattern Recognition, Automated | 2 | 2016 | 987 | 0.150 |
Why?
|
Gallium Radioisotopes | 1 | 2019 | 195 | 0.150 |
Why?
|
Diuretics | 2 | 2015 | 614 | 0.150 |
Why?
|
Aged | 28 | 2024 | 171319 | 0.150 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2270 | 0.150 |
Why?
|
Acetates | 1 | 2019 | 314 | 0.140 |
Why?
|
Ethylene Glycols | 1 | 2018 | 197 | 0.140 |
Why?
|
Cerebral Hemorrhage | 2 | 2019 | 2655 | 0.140 |
Why?
|
Aged, 80 and over | 17 | 2024 | 59548 | 0.130 |
Why?
|
Mouth Neoplasms | 1 | 2021 | 597 | 0.130 |
Why?
|
Male | 39 | 2024 | 364203 | 0.130 |
Why?
|
Humans | 54 | 2024 | 767040 | 0.130 |
Why?
|
Brain Stem | 1 | 2021 | 858 | 0.130 |
Why?
|
Neoadjuvant Therapy | 4 | 2011 | 2902 | 0.130 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4560 | 0.130 |
Why?
|
Cerebral Infarction | 1 | 2020 | 968 | 0.130 |
Why?
|
Models, Neurological | 2 | 2022 | 1747 | 0.120 |
Why?
|
Pulmonary Fibrosis | 1 | 2019 | 505 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2024 | 16036 | 0.120 |
Why?
|
Organ Size | 1 | 2020 | 2264 | 0.120 |
Why?
|
Thalamus | 1 | 2021 | 1040 | 0.120 |
Why?
|
Female | 34 | 2024 | 396660 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1089 | 0.110 |
Why?
|
Electrolytes | 1 | 2015 | 279 | 0.110 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2015 | 167 | 0.110 |
Why?
|
Severity of Illness Index | 4 | 2024 | 15925 | 0.110 |
Why?
|
Aniline Compounds | 1 | 2018 | 1080 | 0.100 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 180 | 0.100 |
Why?
|
Radiation, Ionizing | 1 | 2013 | 252 | 0.100 |
Why?
|
Neoplastic Stem Cells | 1 | 2020 | 1349 | 0.100 |
Why?
|
Arterial Occlusive Diseases | 3 | 2020 | 743 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2016 | 3370 | 0.100 |
Why?
|
Head and Neck Neoplasms | 2 | 2020 | 2930 | 0.100 |
Why?
|
Feces | 2 | 2009 | 1508 | 0.090 |
Why?
|
Stochastic Processes | 1 | 2013 | 359 | 0.090 |
Why?
|
Cohort Studies | 6 | 2021 | 41718 | 0.090 |
Why?
|
Artifacts | 1 | 2020 | 1904 | 0.090 |
Why?
|
Micronucleus Tests | 1 | 2010 | 23 | 0.090 |
Why?
|
Thymidylate Synthase | 1 | 2011 | 74 | 0.090 |
Why?
|
Leukocyte L1 Antigen Complex | 2 | 2009 | 93 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.090 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1012 | 0.090 |
Why?
|
Indoles | 1 | 2019 | 1836 | 0.090 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.090 |
Why?
|
Lactoferrin | 2 | 2009 | 100 | 0.090 |
Why?
|
Hypertension | 2 | 2022 | 8615 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 1761 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2800 | 0.090 |
Why?
|
Prognosis | 6 | 2024 | 29963 | 0.080 |
Why?
|
Mutation | 4 | 2016 | 30211 | 0.080 |
Why?
|
Bayes Theorem | 3 | 2022 | 2353 | 0.080 |
Why?
|
Carcinoembryonic Antigen | 1 | 2011 | 338 | 0.080 |
Why?
|
Cystitis | 1 | 2009 | 96 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2979 | 0.080 |
Why?
|
Enteritis | 1 | 2009 | 164 | 0.080 |
Why?
|
Neural Pathways | 1 | 2019 | 3078 | 0.080 |
Why?
|
Polymorphism, Genetic | 3 | 2015 | 4247 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1759 | 0.070 |
Why?
|
Genes, ras | 1 | 2010 | 656 | 0.070 |
Why?
|
Reactive Oxygen Species | 2 | 2013 | 2144 | 0.070 |
Why?
|
Receptors, Chemokine | 1 | 2010 | 652 | 0.070 |
Why?
|
Large Neutral Amino Acid-Transporter 1 | 1 | 2007 | 15 | 0.070 |
Why?
|
Amino Acid Transport System y+ | 1 | 2007 | 40 | 0.070 |
Why?
|
Positron-Emission Tomography | 3 | 2019 | 6550 | 0.070 |
Why?
|
Receptors, Drug | 1 | 2007 | 156 | 0.070 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2007 | 106 | 0.070 |
Why?
|
Spondylitis, Ankylosing | 1 | 2008 | 158 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2011 | 11872 | 0.070 |
Why?
|
Chemokines | 1 | 2010 | 963 | 0.070 |
Why?
|
Brain Mapping | 2 | 2021 | 6597 | 0.070 |
Why?
|
Cell Survival | 2 | 2019 | 5750 | 0.070 |
Why?
|
Adenocarcinoma | 2 | 2016 | 6360 | 0.060 |
Why?
|
Meteoroids | 1 | 2005 | 1 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18063 | 0.060 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2008 | 392 | 0.060 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2010 | 699 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2009 | 645 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 347 | 0.060 |
Why?
|
Melphalan | 1 | 2007 | 421 | 0.060 |
Why?
|
Prenatal Diagnosis | 1 | 2013 | 1271 | 0.060 |
Why?
|
Reference Values | 1 | 2013 | 4918 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3792 | 0.060 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 246 | 0.060 |
Why?
|
Disability Evaluation | 2 | 2024 | 1829 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2024 | 15424 | 0.060 |
Why?
|
Treatment Outcome | 10 | 2021 | 65295 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2013 | 1672 | 0.060 |
Why?
|
Blood-Borne Pathogens | 1 | 2004 | 52 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2021 | 7868 | 0.060 |
Why?
|
Sulfonamides | 3 | 2015 | 1982 | 0.060 |
Why?
|
ras Proteins | 1 | 2009 | 1054 | 0.060 |
Why?
|
Symporters | 1 | 2007 | 363 | 0.060 |
Why?
|
Chromosome Aberrations | 1 | 2010 | 1776 | 0.060 |
Why?
|
Dementia | 1 | 2019 | 2741 | 0.060 |
Why?
|
Premature Birth | 1 | 2016 | 1830 | 0.060 |
Why?
|
Phenotype | 6 | 2024 | 16718 | 0.060 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2007 | 614 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2698 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8531 | 0.050 |
Why?
|
Neoplasm Staging | 6 | 2016 | 11217 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26325 | 0.050 |
Why?
|
Image Enhancement | 1 | 2013 | 2867 | 0.050 |
Why?
|
Risk Factors | 7 | 2024 | 74886 | 0.050 |
Why?
|
Rheumatology | 1 | 2008 | 617 | 0.050 |
Why?
|
Combined Modality Therapy | 5 | 2011 | 8535 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18401 | 0.050 |
Why?
|
Up-Regulation | 1 | 2010 | 4143 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14672 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5446 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2017 | 5754 | 0.050 |
Why?
|
Genotype | 4 | 2009 | 13035 | 0.050 |
Why?
|
Bumetanide | 2 | 2015 | 101 | 0.050 |
Why?
|
Genetic Association Studies | 2 | 2024 | 2744 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20169 | 0.040 |
Why?
|
Retrospective Studies | 8 | 2024 | 81659 | 0.040 |
Why?
|
Furosemide | 2 | 2015 | 174 | 0.040 |
Why?
|
Adult | 12 | 2022 | 223317 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2009 | 4616 | 0.040 |
Why?
|
Calcium | 1 | 2013 | 5792 | 0.040 |
Why?
|
Brain Edema | 1 | 2024 | 601 | 0.040 |
Why?
|
Pedigree | 1 | 2008 | 4539 | 0.040 |
Why?
|
Base Sequence | 2 | 2008 | 12414 | 0.040 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2009 | 2058 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2008 | 1814 | 0.040 |
Why?
|
Reperfusion | 1 | 2020 | 268 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4114 | 0.040 |
Why?
|
Adolescent | 3 | 2021 | 89046 | 0.040 |
Why?
|
Biological Products | 1 | 2008 | 948 | 0.040 |
Why?
|
Basilar Artery | 1 | 2019 | 207 | 0.040 |
Why?
|
Vertebral Artery | 1 | 2019 | 185 | 0.040 |
Why?
|
Cerebral Revascularization | 1 | 2021 | 260 | 0.040 |
Why?
|
Antirheumatic Agents | 1 | 2008 | 1379 | 0.040 |
Why?
|
Monocytes | 1 | 2008 | 2598 | 0.040 |
Why?
|
Premenopause | 1 | 2022 | 1039 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3702 | 0.040 |
Why?
|
Gamma Rays | 1 | 2019 | 324 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2010 | 9532 | 0.040 |
Why?
|
Bacteremia | 1 | 2004 | 983 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 4522 | 0.040 |
Why?
|
Potassium | 2 | 2015 | 1314 | 0.030 |
Why?
|
Haplotypes | 3 | 2009 | 2722 | 0.030 |
Why?
|
Algorithms | 2 | 2019 | 14098 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3797 | 0.030 |
Why?
|
RNA, Neoplasm | 2 | 2011 | 748 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4349 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13650 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13411 | 0.030 |
Why?
|
Apoptosis | 2 | 2011 | 9513 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2018 | 405 | 0.030 |
Why?
|
Prostatic Neoplasms | 2 | 2009 | 11097 | 0.030 |
Why?
|
Introns | 2 | 2009 | 965 | 0.030 |
Why?
|
Triamterene | 1 | 2015 | 4 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4405 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 17608 | 0.030 |
Why?
|
Cross-Over Studies | 2 | 2015 | 2105 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 4049 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2003 | 2028 | 0.030 |
Why?
|
Thermodynamics | 1 | 2016 | 581 | 0.030 |
Why?
|
Hydrochlorothiazide | 1 | 2015 | 95 | 0.030 |
Why?
|
Registries | 2 | 2021 | 8351 | 0.030 |
Why?
|
Reaction Time | 1 | 2021 | 2086 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1331 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4648 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2429 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2003 | 2702 | 0.030 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2013 | 159 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2019 | 935 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2010 | 2915 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10622 | 0.030 |
Why?
|
Cisplatin | 1 | 2019 | 1656 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2616 | 0.030 |
Why?
|
Arthritis, Rheumatoid | 1 | 2008 | 3778 | 0.030 |
Why?
|
Sodium Chloride | 1 | 2015 | 580 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2021 | 1886 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9410 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2054 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2008 | 18989 | 0.020 |
Why?
|
Linkage Disequilibrium | 2 | 2009 | 1996 | 0.020 |
Why?
|
Genome, Human | 1 | 2005 | 4441 | 0.020 |
Why?
|
Survival Analysis | 2 | 2020 | 10092 | 0.020 |
Why?
|
Kidney | 1 | 2007 | 7063 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6067 | 0.020 |
Why?
|
Preoperative Care | 2 | 2011 | 2252 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2015 | 1587 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6966 | 0.020 |
Why?
|
Radiotherapy, High-Energy | 1 | 2011 | 228 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39317 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1647 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2004 | 5345 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2010 | 12793 | 0.020 |
Why?
|
Hot Temperature | 1 | 2016 | 1441 | 0.020 |
Why?
|
Cytokinesis | 1 | 2010 | 170 | 0.020 |
Why?
|
3' Flanking Region | 1 | 2009 | 14 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2010 | 876 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40154 | 0.020 |
Why?
|
Antibodies, Bispecific | 1 | 2011 | 204 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13646 | 0.020 |
Why?
|
Austria | 1 | 2008 | 207 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1697 | 0.020 |
Why?
|
Mass Screening | 1 | 2003 | 5456 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2009 | 826 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1969 | 0.020 |
Why?
|
Thiazides | 1 | 2007 | 19 | 0.020 |
Why?
|
Granulocytes | 1 | 2009 | 551 | 0.020 |
Why?
|
Biotransformation | 1 | 2006 | 165 | 0.020 |
Why?
|
Prospective Studies | 4 | 2019 | 54886 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 2628 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2009 | 959 | 0.020 |
Why?
|
Mice | 3 | 2019 | 81912 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 361 | 0.020 |
Why?
|
Jupiter | 1 | 2005 | 1 | 0.020 |
Why?
|
Cosmic Dust | 1 | 2005 | 2 | 0.020 |
Why?
|
Photometry | 1 | 2005 | 55 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1741 | 0.020 |
Why?
|
Oligopeptides | 1 | 2011 | 1195 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7848 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2009 | 735 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 8068 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2010 | 935 | 0.010 |
Why?
|
Organic Chemicals | 1 | 2005 | 211 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8628 | 0.010 |
Why?
|
United States | 1 | 2013 | 72971 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2009 | 1615 | 0.010 |
Why?
|
Oncology Service, Hospital | 1 | 2004 | 55 | 0.010 |
Why?
|
Withholding Treatment | 1 | 2008 | 619 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2010 | 1512 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10455 | 0.010 |
Why?
|
Penetrance | 1 | 2005 | 388 | 0.010 |
Why?
|
Cell Division | 1 | 2011 | 4473 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2350 | 0.010 |
Why?
|
Cognition | 1 | 2021 | 7059 | 0.010 |
Why?
|
Risk Assessment | 2 | 2020 | 24299 | 0.010 |
Why?
|
Pharmacogenetics | 1 | 2007 | 682 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2900 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2827 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1743 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15645 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4855 | 0.010 |
Why?
|
Exons | 1 | 2007 | 2391 | 0.010 |
Why?
|
Animals | 3 | 2019 | 168965 | 0.010 |
Why?
|
DNA Damage | 1 | 2010 | 2469 | 0.010 |
Why?
|
Echocardiography | 1 | 2013 | 5042 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22254 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3804 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2794 | 0.010 |
Why?
|
Brazil | 1 | 2004 | 1250 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2008 | 1794 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2007 | 1372 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18330 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6513 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2476 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6777 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2850 | 0.010 |
Why?
|
Gene Frequency | 1 | 2005 | 3621 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2004 | 3431 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10748 | 0.010 |
Why?
|
Acute Disease | 1 | 2008 | 7236 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2008 | 2780 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12823 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 7587 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5796 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6215 | 0.010 |
Why?
|
Neoplasms | 1 | 2004 | 22350 | 0.010 |
Why?
|
Child | 1 | 2022 | 80771 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2004 | 6310 | 0.010 |
Why?
|
Alleles | 1 | 2005 | 6893 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 17097 | 0.010 |
Why?
|
Body Mass Index | 1 | 2011 | 13048 | 0.010 |
Why?
|
Genetic Variation | 1 | 2007 | 6611 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2007 | 5186 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 59980 | 0.000 |
Why?
|
Signal Transduction | 1 | 2010 | 23621 | 0.000 |
Why?
|
Incidence | 1 | 2004 | 21526 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 7469 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2004 | 15824 | 0.000 |
Why?
|